RAYBETÀ×¾º¼¼¼¯ÍÅ8¸öÐÂũҩͨÓÃÃû»ñISOÔÝʱÅú×¼ |
ʱ¼ä£º2012-08-23 ȪԴ£ºRAYBETÀ×¾º¼¼¼¯ÍÅ ÊÓÁ¦±£»£»¤É«£º |
¿ËÈÕ£¬£¬£¬£¬£¬ÓÉRAYBETÀ×¾º¼¼¼¯ÍÅÏà¹ØÆóÒµÑз¢µÄ8ÖÖÐÂũҩÓÐÓÃÒòËØ£¬£¬£¬£¬£¬ÆäͨÓÃÃû³Æ»ñ¹ú¼Ê±ê×¼»¯×éÖ¯£¨ISO£©Å©Ò©ÃüÃûÊÖÒÕίԱ»áÔÝʱÅú×¼¡£¡£ÆäÖУ¬£¬£¬£¬£¬6ÖÖÓÉÎÒ˾ÏÂÊôÉòÑô»¯¹¤Ñо¿ÔºÓÐÏÞ¹«Ë¾¿ª·¢£¬£¬£¬£¬£¬ÆäÓà2ÖÖ»®·ÖÓÉÎÒ˾ÏÂÊôÉòÑô¿Æ´´»¯Ñ§Æ·ÓÐÏÞ¹«Ë¾¼°ÎÒ˾²Î¹ÉÆóÒµÑïÅ©¼¯ÍÅÏÂÊôµÄ½ËÕÓÅÊ¿»¯Ñ§ÓÐÏÞ¹«Ë¾Ñз¢ËùµÃ¡£¡£ ÆäÖУ¬£¬£¬£¬£¬ÉòÑô»¯¹¤Ñо¿Ôº¿ª·¢ËùµÃµÄ6ÖÖɱ¾ú¼ÁµÄͨÓÃÃû°üÀ¨£ºcoumoxystrobin¶¡Ïã¾úõ¥¡¢ enoxastrobinϩ뿾úõ¥¡¢flufenoxystrobin·ú¾úòýõ¥£¬£¬£¬£¬£¬fenamistrobinϩ뿾ú°·¡¢tricyclopyricarbÂÈाúõ¥£¬£¬£¬£¬£¬ÒÔ¼°pyrisoxazoleाú‡fßò£¬£¬£¬£¬£¬ÉòÑô¿Æ´´Ñз¢ËùµÃµÄɱòý¼ÁͨÓÃÃûΪpyriminostrobinà×òý°·£¬£¬£¬£¬£¬ÓÅÊ¿»¯Ñ§Ñз¢µÄÄâ³ý³æ¾Õõ¥Ààɱ³æ¼ÁͨÓÃÃûΪheptafluthrin¡£¡£ ´Ë´Îͨ¹ýISOÔÝʱÅú×¼£¬£¬£¬£¬£¬Òâζ×ÅÎÒ˾¾ßÓÐ×ÔÖ÷֪ʶ²úȨµÄÉÏÊö8ÖÖÐÂũҩµÄÐÔÄÜ»ñµÃÁ˹ú¼ÊÒµ½çÈϿɣ¬£¬£¬£¬£¬ÓµÓÐÁËÈ«ÇòͨÓõġ¢Î¨Ò»ÎÞ¶þµÄÓ¢ÎÄÃû³Æ¡£¡£ ![]() |